Cytomegalovirus Donor and Recipient Serostatus and 5‐Year Mortality After Heart Transplantation: Evidence of Racial Differences

BACKGROUND: Cytomegalovirus (CMV) donor/recipient (D/R) serostatus is an established determinant of post-transplant outcomes in heart transplantation (HT); however, the extent to which demographic and socioeconomic (SE) factors modify CMV-related mortality risk remains unclear. METHODS: Using the scientific registry of transplant recipients, we evaluated whether demographic and SE factors alter the association between CMV D/R serostatus and 5-year all-cause mortality among first-time, adult HT recipients (2010-2024). Multivariable competing risk models estimated sub-distribution hazard ratios (sHRs) for CMV D/R serostatus interacted with age, sex, race/ethnicity, and Distressed Community Index (DCI) categories. RESULTS: CMV D+/R- and CMV D+/R+ serostatus were associated with increased 5-year mortality. Effect modification varied by subgroup. Age, sex, and DCI did not significantly modify CMV-associated mortality, suggesting consistent relative risk across these strata. In contrast, race/ethnicity significantly modified the association with attenuated mortality among Black HT recipients compared with White HT recipients (reference). The sHR for mortality comparing Black CMV D-/R- and CMV D+/R+ HT recipients was 0.69 lower (95% CI: 0.57-0.84; p-value < 0.001) than the corresponding estimate in White HT recipients. Similarly, the sHR comparing Black CMV D-/R- and CMV D-/R+ HT recipients was 0.78 lower (95% CI: 0.63-0.97; p-value = 0.024) than the White HT recipients. No significant differences were observed between White and Hispanic/Other racial/ethnic groups. CONCLUSIONS: CMV-related mortality risk was evident among White recipients, however, the effect of CMV on post-transplant outcomes is attenuated in Black recipients. These findings highlight heterogeneity in CMV-associated risk and support more individualized CMV prevention and monitoring strategies incorporating demographic context.

Authors

Institutions

Publication Details

Journal
Transplant Infectious Disease
Published
2026-10-27
DOI
https://doi.org/10.1111/tid.70341
Primary Topic
Transplantation: Methods and Outcomes
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cytomegalovirus Donor and Recipient Serostatus and 5‐Year Mortality After Heart Transplantation: Evidence of Racial Differences

Kristine Mace Erlandson, Jesse D. Schold, Maheen Z. Abidi, Deena N. Brosi et al.
1 links
Transplant Infectious Disease
Transplantation: Methods and Outcomes
article

Cytomegalovirus Donor and Recipient Serostatus and 5‐Year Mortality After Heart Transplantation: Evidence of Racial Differences

Kristine Mace Erlandson, Jesse D. Schold, Maheen Z. Abidi, Deena N. Brosi, William A. Werbel, Sara Belga, Adriana Weinberg
article en

Abstract

BACKGROUND: Cytomegalovirus (CMV) donor/recipient (D/R) serostatus is an established determinant of post-transplant outcomes in heart transplantation (HT); however, the extent to which demographic and socioeconomic (SE) factors modify CMV-related mortality risk remains unclear. METHODS: Using the scientific registry of transplant recipients, we evaluated whether demographic and SE factors alter the association between CMV D/R serostatus and 5-year all-cause mortality among first-time, adult HT recipients (2010-2024). Multivariable competing risk models estimated sub-distribution hazard ratios (sHRs) for CMV D/R serostatus interacted with age, sex, race/ethnicity, and Distressed Community Index (DCI) categories. RESULTS: CMV D+/R- and CMV D+/R+ serostatus were associated with increased 5-year mortality. Effect modification varied by subgroup. Age, sex, and DCI did not significantly modify CMV-associated mortality, suggesting consistent relative risk across these strata. In contrast, race/ethnicity significantly modified the association with attenuated mortality among Black HT recipients compared with White HT recipients (reference). The sHR for mortality comparing Black CMV D-/R- and CMV D+/R+ HT recipients was 0.69 lower (95% CI: 0.57-0.84; p-value < 0.001) than the corresponding estimate in White HT recipients. Similarly, the sHR comparing Black CMV D-/R- and CMV D-/R+ HT recipients was 0.78 lower (95% CI: 0.63-0.97; p-value = 0.024) than the White HT recipients. No significant differences were observed between White and Hispanic/Other racial/ethnic groups. CONCLUSIONS: CMV-related mortality risk was evident among White recipients, however, the effect of CMV on post-transplant outcomes is attenuated in Black recipients. These findings highlight heterogeneity in CMV-associated risk and support more individualized CMV prevention and monitoring strategies incorporating demographic context.

Transplant Infectious Disease
University of British Columbia (CA), Johns Hopkins University (US), Johns Hopkins Medicine (US), Mayo Clinic in Arizona (US), Mayo Clinic Hospital (US), University of Colorado Anschutz Medical Campus (US)
Health Resources and Services Administration
Good health and well-being, Reduced inequalities
Openalex Percentile: Top 10%
Transplantation: Methods and Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon